Evidence map›Paper›PMID 34536168›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2021

Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.

Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, Maria Alsina, Mustafa Özgüroğlu, Yung-Jue Bang, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Al B Benson and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Eric Van CutsemDepartment of Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, 49 Herestraat, Leuven, Belgium. eric.vancutsem@uzleuven.be.
Mayur AmonkarCenter for Observational and Real World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
Charles S FuchsYale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Maria AlsinaDepartment of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, University Autònoma de Barcelona, Barcelona, Spain.
Mustafa ÖzgüroğluDepartment of Internal Medicine, Medical Oncology, and Clinical Trial Unit, Cerrahpaşa School of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
Yung-Jue BangDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Hyun Cheol ChungDepartment of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Kei MuroDepartment of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Eray GoekkurtNorth-German Trial Center for Innovative Oncology, Hematology Oncology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany.
Al B BensonRobert H. Lurie Comprehensive Cancer Center, Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Weijing SunDepartment of Internal Medicine and Medical Oncology, University of Kansas, Westwood, KS, USA.
Zev A WainbergDepartment of Medicine and Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Josephine M NorquistCenter for Observational and Real World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
Xinqun ChenDepartment of Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.
Chie-Schin ShihDepartment of Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.
Kohei ShitaraDepartment of Gastrointestinal Oncology, National Cancer Center Hospital, Chiba, Japan.ORCID http://orcid.org/0000-0001-5196-3630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34536168
PMCPMC9172792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.